Market Research Logo

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney Disease - Pipeline Review, H2 20


Introduction
Global Markets Direct Report Coverage
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Companies Involved in Therapeutics Development
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Drug Profiles
AB-023 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for Peripheral Arterial Disease and End-Stage Kidney Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Plasma Gelsolin Replacement for Renal Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Sanguinate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tesidolumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Dormant Projects
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), H2 2018
Number of Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by Novartis AG, H2 2018
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by Prolong Pharmaceuticals LLC, H2 2018
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by VESSL Therapeutics Ltd, H2 2018
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Dormant Projects, H2 2018
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report